Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

PubMed

Impact of Aneurysm Size and Flow Diverter Use on Outcomes After Endovascular Therapy of Unruptured Paraclinoid Aneurysms.

PMID: 42088337 · 2026

JournalStroke (Hoboken, N.J.)
Year2026
PMID42088337

Abstract

Flow diverters (FDs) are increasingly used for unruptured paraclinoid aneurysms, especially large or giant ones. However, their benefit over conventional endovascular therapy remains unclear. This study evaluated outcomes after endovascular therapy of unruptured paraclinoid aneurysms, with aneurysm size as the primary exposure, and further examined the modifying effect of FD use. We analyzed data of patients with unruptured paraclinoid aneurysms from the Japanese Registry of Neuroendovascular Th

Official Source

View on PubMed →

Data sourced from PubMed / NCBI. For the full text and most current information, always refer to the official record.